“telaprevir” Archives

Entry Author Date Location
Take a Grain of Salt (Or Two) With New Cholesterol Drug Predictions 06/09/15 National
Vertex Teams up With Durham’s Parion in $80M Lung Drug Deal 06/04/15 Boston
FDA Panel Backs Vertex’s Two-Drug Combo For Cystic Fibrosis 05/12/15 Boston
The Innovation Challenge: Assessing BioPharma Startups 05/04/15 Seattle
Vertex Buys Spine Drug on the QT As Part of Its Post-Hep C Makeover 02/20/15 Boston
East Coast Biotech Roundup: Alnylam, Stock Offerings, Curis, & More 01/23/15 Boston
Hepatitis C Commercial Game Theory 01/01/15 National
East Coast Biotech Roundup: Amicus, Accelerator, Seventh Sense, & More 08/15/14 Boston
Enanta, No Longer Obscure, Seeks Slice of Big Hepatitis C Market 01/24/14 Boston
Vertex Sells Hep C Drug Royalty Rights to Janssen for $152M 11/20/13 Boston
Vertex Cuts 15% of Workforce as Hepatitis C Drug Sales Drop 10/29/13 Boston
Vertex Sees Liver Toxicity With Emerging Hep C Drug, Faces FDA Hold 07/25/13 Boston
Pfizer Yields to Rivals in Hep C Drug Race 03/13/13 New York
East Coast Life Sciences Roundup: Vertex, Thermedical, More 11/02/12 Boston
Kinsella Redux: Charting a Way Back for Life Sciences Startups 09/27/12 San Diego
Vertex Stays in HepC Game, as All-Oral Combo Passes Small Study 02/23/12 Boston
Vertex Vows to Fight On With Alios Drugs in High-Stakes Hepatitis C Race 01/24/12 Boston
Vertex Names Jeff Leiden as New CEO, Staring Down Tough Competition 12/15/11 Boston
The Hepatitis C Market: Biotech’s Version of the Daytona 500 12/12/11 National
Rempex Raises $67.5M, Vertex Shares Tumble, & More San Diego Life Sciences News 11/10/11 San Diego
TEDMED Walking, FDA Clears Pacira Drug, Zogenix Close to NDA, & More San Diego Life Sciences News 11/03/11 San Diego
Dendreon Wounds Are Self-Inflicted, Not the Start of a Biotech Industry Virus 08/08/11 National
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News 08/04/11 San Diego
Vertex Smashes Wall Street Sales Expectations In Hepatitis C Drug Debut 07/28/11 Boston
Vertex Adds New HepC Drugs for $60M 06/13/11 Boston
Vertex Gets FDA OK, Alnylam Plans For ASCO, Biogen Drug Advances in Europe, & More Boston-Area Life Sciences News 05/27/11 Boston
Nestlé Acquires Prometheus, Trius Raises $30M in Private Placement, Canaan’s Bloch Discusses Advanced BioHealing Deal, & More San Diego Life Sciences News 05/26/11 San Diego
Vertex, On Deadline, Wins FDA Approval for Hepatitis C Drug 05/23/11 Boston
Why Are Drugs Getting Such Weird Brand Names? 05/09/11 National
Vertex Signs Boston Lease 05/05/11 Boston
Page 1 of 3 next page »